Thomas Dayspring

882 total citations
33 papers, 617 citations indexed

About

Thomas Dayspring is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Thomas Dayspring has authored 33 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 12 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Cancer Research. Recurrent topics in Thomas Dayspring's work include Lipoproteins and Cardiovascular Health (20 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers) and Cancer, Lipids, and Metabolism (10 papers). Thomas Dayspring is often cited by papers focused on Lipoproteins and Cardiovascular Health (20 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers) and Cancer, Lipids, and Metabolism (10 papers). Thomas Dayspring collaborates with scholars based in United States. Thomas Dayspring's co-authors include Peter P. Tóth, Binh An P. Phan, Joseph P. McConnell, William S. Harris, Dawn L. Thiselton, Daniel M Hoefner, G. Russell Warnick, Stephen A. Varvel, Cheryl Keech and Yongming Qu and has published in prestigious journals such as Journal of the American College of Cardiology, The American Journal of Cardiology and Obstetrics and Gynecology.

In The Last Decade

Thomas Dayspring

29 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Dayspring United States 14 342 183 125 101 84 33 617
Martin P. Bogsrud Norway 20 739 2.2× 241 1.3× 274 2.2× 229 2.3× 118 1.4× 84 1.1k
Peter D. Montan United States 11 197 0.6× 163 0.9× 98 0.8× 69 0.7× 103 1.2× 14 492
Matthias Nauck Germany 12 361 1.1× 396 2.2× 100 0.8× 78 0.8× 74 0.9× 17 707
Eliscer Guzman United States 17 374 1.1× 337 1.8× 256 2.0× 119 1.2× 194 2.3× 28 1.0k
Anastazia Kei Greece 13 262 0.8× 185 1.0× 114 0.9× 67 0.7× 106 1.3× 34 548
Andreas Sourlas Greece 12 240 0.7× 172 0.9× 117 0.9× 83 0.8× 102 1.2× 18 517
Margherita Botta Italy 11 272 0.8× 113 0.6× 74 0.6× 80 0.8× 225 2.7× 17 602
Graeme W. Tait United Kingdom 6 433 1.3× 470 2.6× 220 1.8× 128 1.3× 73 0.9× 9 765
Rafael Bitzur Israel 13 228 0.7× 244 1.3× 87 0.7× 56 0.6× 167 2.0× 30 712
Vana Kolovou Greece 17 242 0.7× 141 0.8× 166 1.3× 77 0.8× 134 1.6× 49 673

Countries citing papers authored by Thomas Dayspring

Since Specialization
Citations

This map shows the geographic impact of Thomas Dayspring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Dayspring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Dayspring more than expected).

Fields of papers citing papers by Thomas Dayspring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Dayspring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Dayspring. The network helps show where Thomas Dayspring may publish in the future.

Co-authorship network of co-authors of Thomas Dayspring

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Dayspring. A scholar is included among the top collaborators of Thomas Dayspring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Dayspring. Thomas Dayspring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vörös, Szilárd, Anthony Lozama, David Watson, et al.. (2025). FIRST DEMONSTRATION BY CARDIAC COMPUTED TOMOGRAPHY THAT LP(A) DRIVES CORONARY PLAQUE DEVELOPMENT IN PATIENTS WITH LOW APOB AND LOW LDL-C LEVELS. Journal of the American College of Cardiology. 85(12). 1832–1832.
2.
Safarova, Maya, et al.. (2025). Inadequate Response to PCSK9 Inhibitors. JACC Case Reports. 30(8). 103696–103696.
3.
4.
Simon, James A., Ayman Al‐Hendy, David F. Archer, et al.. (2020). Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas. Obstetrical & Gynecological Survey. 75(9). 545–547. 2 indexed citations
5.
Simon, James A., Ayman Al‐Hendy, David F. Archer, et al.. (2020). Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas. Obstetrics and Gynecology. 135(6). 1313–1326. 44 indexed citations
6.
Dayspring, Thomas, et al.. (2015). Biomarkers of cholesterol homeostasis in a clinical laboratory database sample comprising 667,718 patients. Journal of clinical lipidology. 9(6). 807–816. 28 indexed citations
7.
Backes, James M., Thomas Dayspring, Daniel M Hoefner, & Patrick M. Moriarty. (2015). Hypertriglyceridaemia unresponsive to multiple treatments. BMJ Case Reports. 2015. bcr2015210788–bcr2015210788. 4 indexed citations
8.
Pottala, James V., Maciek Sasinowski, Thomas Dayspring, et al.. (2015). Comparison of cardiometabolic risk biomarkers from a national clinical laboratory with the US adult population. Journal of clinical lipidology. 9(6). 817–823. 8 indexed citations
9.
McConnell, Joseph P., et al.. (2014). Lipoprotein(a) mass: A massively misunderstood metric. Journal of clinical lipidology. 8(6). 550–553. 43 indexed citations
10.
Dayspring, Thomas, et al.. (2014). Validation of a lipoprotein(a) particle concentration assay by quantitative lipoprotein immunofixation electrophoresis. Clinica Chimica Acta. 439. 219–224. 19 indexed citations
11.
Harris, William S., James V. Pottala, Dawn L. Thiselton, et al.. (2014). Does APOE Genotype Modify the Relations Between Serum Lipid and Erythrocyte Omega-3 Fatty Acid Levels?. Journal of Cardiovascular Translational Research. 7(5). 526–32. 7 indexed citations
12.
Varvel, Stephen A., Thomas Dayspring, Dawn L. Thiselton, et al.. (2014). Discordance between apolipoprotein B and low-density lipoprotein particle number is associated with insulin resistance in clinical practice. Journal of clinical lipidology. 9(2). 247–255. 19 indexed citations
13.
Harris, William S., et al.. (2013). Omega-3 Fatty Acids and Cardiovascular Disease: New Developments and Applications. Postgraduate Medicine. 125(6). 100–113. 53 indexed citations
14.
15.
Backes, James M., et al.. (2012). Pseudohypertriglyceridemia: Two cases of probable glycerol kinase deficiency. Journal of clinical lipidology. 6(5). 469–473. 12 indexed citations
16.
Dayspring, Thomas, et al.. (2010). Impact of triglycerides on lipid and lipoprotein biology in women. Gender Medicine. 7(3). 189–205. 14 indexed citations
17.
Tóth, Peter P., et al.. (2008). Drug therapy for hypertriglyceridemia: Fibrates and omega-3 fatty acids. Current Atherosclerosis Reports. 11(1). 71–79. 25 indexed citations
18.
Dayspring, Thomas. (2007). High‐Density Lipoproteins: Emerging Knowledge. PubMed. 2(1). 59–62. 3 indexed citations
19.
Dayspring, Thomas, et al.. (2006). Fibrate therapy in patients with metabolic syndrome and diabetes mellitus. Current Atherosclerosis Reports. 8(5). 356–364. 13 indexed citations
20.
Dayspring, Thomas. (2003). Coronary heart disease in women: triglycerides and lipoprotein biology.. PubMed. 5(5). 27–33. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin P. Bogsrud Breakdown of academic impact, for papers by Peter D. Montan Breakdown of academic impact, for papers by Matthias Nauck Breakdown of academic impact, for papers by Eliscer Guzman Breakdown of academic impact, for papers by Anastazia Kei Breakdown of academic impact, for papers by Andreas Sourlas Breakdown of academic impact, for papers by Margherita Botta Breakdown of academic impact, for papers by Graeme W. Tait Breakdown of academic impact, for papers by Rafael Bitzur Breakdown of academic impact, for papers by Vana Kolovou
Rankless by CCL
2026